Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso

Sodiomon B. Sirima, Alphonse Ouedraogo,Nouhoun Barry, Mohamadou Siribie,Alfred B. Tiono,Issa Nébié, Amadou T. Konaté,Gloria Damoaliga Berges,Amidou Diarra, Moussa Ouedraogo,Issiaka Soulama,Alimatou Hema, Shrimati Datta,Yuanyuan Liang, Elizabeth T. Rotrosen,J. Kathleen Tracy,Leslie P. Jamka, Kathleen M. Neuzil,Matthew B. Laurens

International Journal of Infectious Diseases（2021）

引用 19|浏览51

暂无评分

摘要

•This is the first study on the co-administration of typhoid conjugate vaccine (TCV) in West Africa.•Co-administration of TCV with routine vaccines in a typhoid-endemic country was successful.•TCV was safely co-administered at 15 months with group A meningococcal conjugate vaccine.•Single-dose TCV was immunogenic in 15-month-old children.•There was no safety signal related to TCV vaccination or co-administration.

查看译文

关键词

Typhoid conjugate vaccine,Meningococcal vaccines,Measles–rubella vaccine,Co-administration,Sub-Saharan Africa,Burkina Faso

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要